Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. Fehlings, Y. Simoni, H. L. Penny, E. Becht, C. Y. Loh, M. M. Gubin, J. P. Ward, S. C. Wong, R. D. Schreiber, E. W. Newell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf56
record_format dspace
spelling oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf562021-12-02T14:39:26ZAuthor Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells10.1038/s41467-018-05468-y2041-1723https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf562018-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05468-yhttps://doaj.org/toc/2041-1723The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.M. FehlingsY. SimoniH. L. PennyE. BechtC. Y. LohM. M. GubinJ. P. WardS. C. WongR. D. SchreiberE. W. NewellNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
description The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.
format article
author M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
author_facet M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
author_sort M. Fehlings
title Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_short Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_fullStr Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full_unstemmed Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_sort author correction: checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific cd8+ t cells
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56
work_keys_str_mv AT mfehlings authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ysimoni authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT hlpenny authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ebecht authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT cyloh authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT mmgubin authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT jpward authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT scwong authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT rdschreiber authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ewnewell authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
_version_ 1718390631056801792